J 2025

Trifluoromethylcinnamanilides - Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum

KOS, Jiří; Tomáš STRHÁRSKY; Rodrigo TOSSO; Lucas GUTIERREZ; Dominika KOS et al.

Základní údaje

Originální název

Trifluoromethylcinnamanilides - Effective dual inhibitors of Mycobacterium smegmatis and Plasmodium falciparum

Autoři

KOS, Jiří; Tomáš STRHÁRSKY; Rodrigo TOSSO; Lucas GUTIERREZ; Dominika KOS ORCID; Jan JUŘICA; Ondřej ZENDULKA; Ondřej PEŠ; Jana GREGOROVÁ ORCID; Gilles DEGOTTE; Tomáš GONĚC ORCID; Michal ORAVEC; Veronika VOJACKOVA; Vladimir KRYSTOF; Alois ČÍŽEK; Pierre FRANCOTTE; Michel FREDERICH; Josef JAMPÍLEK a Daniel ENRIZ

Vydání

Bioorganic Chemistry, SAN DIEGO, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2025, 0045-2068

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30107 Medicinal chemistry

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.700 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00140450

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

Cinnamanilides; Lipophilicity; P. falciparum; Cytotoxicity; Molecular modeling; QTAIM calculations

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 12. 3. 2026 13:32, Mgr. Tereza Miškechová

Anotace

V originále

A series of eighteen new 2-trifluoromethylcinnamanilides (1a-r) were synthesized by microwave synthesis and investigated for their antimycobacterial and antimalarial activities, along with the complementary (2E)-3-[3(trifluoromethyl)phenyl]-N-arylprop-2-enanilides (2a-r) and (2E)-3-[4-(trifluoromethyl)phenyl]-N-arylprop-2enanilides (3a-r) prepared earlier. All the compounds were evaluated in vitro against Mycobacterium smegmatis ATCC 700084 and a chloroquine-sensitive strain of Plasmodium falciparum 3D7/MRA-102. The most active compounds against M. smegmatis (MIC values in the range of 1.17-11.1 mu M, more effective than rifampicin) were anilides substituted by 3,5-CF3 (1q, 2q, 3q), 4-OCF3 (1k), and 4-CF3 (1j, 2j). The most effective agents against P. falciparum (IC50 values in the range of 0.32-4.5 mu M, comparable to chloroquine) were anilides substituted by 3,5-CF3 (1q, 2q, 3q), 2-Br-4-OCF3 (1r), 4-CF3 (1j, 3j), 4-F (2d), 4-Cl (2g), 2-Cl (1e, 2e). A preliminary in vitro cytotoxicity screening was assessed using human leukemic cell lines and human dermal fibroblasts, revealing the toxic effect of 3,5-CF3 substituted anilides. On the other hand, the other investigated agents showed insignificant cytotoxic effects. Stability assays using rat liver microsomes demonstrated that compounds 1r (R = 2-Br-4-OCF3) and 1q (R = 3,5-CF3) are neither metabolized nor affect cytochrome P450 metabolizing capacity in vitro. Furthermore, complex in silico studies were performed - a combined approach (docking/MD simulations/QTAIM calculations) helped to define the molecular interactions that were applied during the binding of active agents and the subsequent inhibition of their molecular targets - InhA (activity against M. smegmatis) and arginase

Návaznosti

90248, velká výzkumná infrastruktura
Název: CzeCOS IV